SS

Saurabh Shankar Kolhe

Active Director Director DIN 11300257
DIN 11300257 First appointment Sep 2025 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Sep 2025
Shareholding value - Across - companies

About Saurabh Shankar Kolhe

Saurabh Shankar Kolhe has experience in corporate governance. Holds Director role. Currently with 1 company, including Riaan Med-Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 11300257
Primary Designation Director
First Appointment 16 Sep 2025
Oldest Company Age Not Provided

Current companies

Company Designation Appointment Founded Status
Riaan Med-Pharma Private Limited U74110MH2017PTC295991
Director 16 Sep 2025 Not Provided Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Riaan Med-Pharma Private Limited

Shareholding

Pro
Shareholding preview is available in the premium director profile.

Shares held, value and quarterly changes across all companies — with the full investment profile.

Unlock shareholding

Frequently Asked Questions about Saurabh Shankar Kolhe

Saurabh Shankar Kolhe has experience in corporate governance. Holds Director role. Currently with 1 company, including Riaan Med-Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Saurabh Shankar Kolhe is associated with 1 company as Director.

Saurabh Shankar Kolhe has expertise in General Business.

Saurabh Shankar Kolhe has extensive experience in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available